Although hepatitis C virus (HCV) is a major cause of viral hepatitis and hepatocellular carcinoma, many aspects of its evolution remain poorly understood. Relevant to its evolution and the development of antiviral drug resistance is the role of recombination in HCV, which has not been resolved using phylogenetic tests. In line with previous studies, we found no strong support for a role of recombination in the dominant subtypes 1A and 1B using phylogenetic approaches. In contrast, signatures of gene conversion were abundant if a population recombination model, which takes into account diversity within and between groups, was used (9676 gene conversion signatures between the genomes of subtypes 1A and 1B and 170 between the NS5A regions of subtypes 1A and 1B and the minor subtypes 1c-1g). The gene conversion signatures coincided with a striking lack of diagnostically informative sites between subtypes and a large number of shared mutations between complete subtype 1A and 1B genomes (0.76 and 62.2 % of nucleotide sites, respectively). Maximum-likelihood trees revealed significant topological incongruence among conserved PFAM domains and genome regions targeted by diagnostic assays, which underpins a major role for recombination. The same results were obtained with smaller numbers of genomes and with only synonymous sites. Topological concordance increased only marginally if larger genome regions were compared. The level of recombination in HCV subtype 1, which is probably significantly higher than can currently be measured, also illustrates the complexity of designing diagnostic assays based on the unusual patterns of genomic diversity of HCV.
INTRODUCTION
On a global level, hepatitis C virus (HCV) causes millions of cases of hepatitis per year. Although some transmission routes have been notoriously difficult to establish (e.g. de Carvalho-Mello et al., 2010) , the most important transmission routes are through intravenous drug use and, before the implementation of routine screening for HCV, the use of contaminated blood and blood products. The latter is thought to have contributed to the global spread of HCV (Magiorkinis et al., 2009) . The majority of patients infected with HCV develop chronic hepatitis, defined as more than 6 months of viraemia (Villano et al., 1999) , which is also the prime cause of hepatocellular carcinoma. Currently, the treatment of choice for chronic hepatitis C is a combination of PEGylated interferon (IFN-a) and ribavirin (Chevaliez et al., 2009) . PEGylated interferon modulates the immune system, while the mechanism of action of ribavirin is unknown. This combined therapy eradicates infection in 40-50 % of patients infected with subtypes 1A and 1B, but only 20 % when dealing with subtypes 2 and 3. Also, within subtype 1, the effectiveness of antivirals and resistance profiles differ, both in vitro and in vivo (Erhardt et al., 2009) . For example, different resistant variants for subtypes 1A and 1B may be selected by telaprevir, which inhibits HCV NS34A protease (McCown et al., 2009) . Given that HCV subtyping is also expected to become important for stratification in clinical trials and, in the longer run, in clinical practice, there is an urgent need for correct HCV subtype identification.
probably considerably underestimated (Simmonds, 2004) . Methods to detect recombination may -depending on the type and amount of data -have little power to detect recombination. One reason for this is that the recombination partners and the derived recombinant sequence need to be distinct and identifiable in a larger set of sequences. In many instances, recombination between closely related sequence variants is probably not detectable (e.g. within patients), because recombinant and parental sequences in many instances cannot be distinguished (Sentandreu et al., 2008) . Similarly, if many signatures of recombination are present in a dataset, the three types of lineage are unlikely to be statistically distinguishable. Finally, recombination is dealt with differently by the phylogenetic optimality criteria used to reconstruct phylogenies. For example, distance-and parsimony-based phylogenetics may incorporate parallel mutations and recombination differently (e.g. distance measures with rate heterogeneity, which allows some sites to evolve much more quickly than others). As a consequence, there is considerable variation in whether or not phylogenetic methods detect the signatures of recombination. Usually, ad hoc criteria such as majority or consensus approaches among recombination detection methods are used, although it may be difficult to justify the setting of these thresholds for the detection of recombination in HCV (Awadalla, 2003; Sentandreu et al., 2008) .
The molecular and evolutionary constraints acting on the HCV genome (e.g. genome-scale ordered RNA structure or GORS), which may constrain the degree and patterns of variability across the HCV genome in complex ways, are well recognized (e.g. Simmonds, 2004) . The relationships between measures of linkage disequilibrium, which summarize patterns of association of nucleotides, and levels of recombination, which reduce skews in the association of nucleotides as a function of physical distance, may be affected profoundly by genome-wide effects such as GORS, because many alternative sites may be involved in structurally or fitness-related compensatory substitutions. Clearly, if the aim is to improve our understanding of the dynamics of the HCV genome across shorter or longer evolutionary timescales, it is important for genotyping tools to incorporate information on the role of recombination (cf. HIV-1; Alcantara et al., 2009) .
Two different forms of recombination processes have been described. One form, reciprocal crossing-over, is the typical form of recombination observed in diploid organisms, in which genome segments are exchanged between chromosomes. Another form, in which asymmetrical forms of crossing-over occur, may lead to the replacement of one sequence variant or allele by another. The latter form of recombination is typically referred to as gene conversion. Because viral sequence data do not allow a sensible distinction between reciprocal recombination and gene conversion, in this study these processes are studied as if they were equivalent and interchangeable. Here, we assess the importance of recombination (or gene conversion) using phylogenetic and population-genetics tests and tools in HCV subtypes 1A and 1B and the minor subtypes 1c-1g.
RESULTS

Recombination and gene conversion
For HCV subtypes 1A and 1B, 458 and 221 complete genomes, respectively, were retrieved from international databases. The datasets are available on request. While none of the recombination breakpoints were detected by all methods implemented in the program RDP, five significant recombination breakpoints were detected in subtypes 1A and 1B collectively, i.e. by Geneconv (2), MaxChi (1), Geneconv (1) and RDP, Geneconv, Bootscan and MaxChi (1). These results are consistent with those of previous studies, in that different phylogenetic methods found only partially overlapping subsets of recombination breakpoints. Given the size of the datasets, the number of breakpoints can be considered rather limited. This scarcity of recombination breakpoints was underpinned using four short regions targeted by diagnostic assays, i.e. the 59 UTR region, the E1 region and the NS5A and NS5B regions, which did not include any recombination breakpoints when using six phylogenetic algorithms to identify breakpoints when analysing subtypes 1A and 1B (Table 1 ). There were very few diagnostic sites and a large number of shared mutations in the NS5B region between subtypes 1A and 1B (Table 1) . In agreement with this, the number of diagnostic sites between complete genomes of HCV subtypes 1A and 1B was larger (67, 0.76 % of the total number of nucleotides sites). The shared mutations between subtypes 1A and 1B (5488, or 62.2 % of nucleotide sites) constitute a far larger fraction of sites. Analyses of linkage disequilibrium indicated no major trend when plotted against physical distance across either the subtype 1A or 1B genomes (r 2 50.0042+0.0000x for subtype 1A, r 2 50.0064+0.0000x for subtype 1B), suggesting that recombination has no clear effect on this measure of linkage disequilibrium. In spite of the large number of shared base substitutions, 42 insertions and deletions (indels) consistently distinguished subtypes 1A and 1B in the entire genome sequences. Evidence for recombination breakpoints was also lacking when subtypes 1A and 1B were compared with the minor subtypes 1c-1g (Table 1) .
In contrast to the phylogenetic approaches, a large number of gene-conversion tracts was found in complete genomes when using the population genetic estimator of Betrán et al. (1997) . Between subtypes 1A and 1B and the minor subtypes (NS5B) and between subtypes 1A and 1B (whole genomes), 170 and 9676 gene-conversion tracts, respectively, were found (Table 1) . Also, in the four diagnostic regions (the 59 UTR region was shortened because many of the HCV genomes included only part of this region), considerable numbers of gene-conversion tracts were found, in agreement with the small number of fixed differences and the large number of shared mutations between subtypes 1A and 1B mentioned before. In all analyses, the gene-conversion tracts were distributed across the entire region or domain investigated, and a substantial number of tracts covered more than two sites that are informative for gene conversion (Fig. 1) .
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Phylogenetic incongruence and recombination
Analyses of the PFAM domains, a comprehensive database of conserved protein families and their alignments, and diagnostic genome regions of subtypes 1A and 1B with RaxML indicated that, when using the GTR model of nucleotide substitution, all trees based on PFAM or diagnostic domains differed significantly from the tree using the complete genomes as a reference (Table 2) . Only one 1.5 kb region did not differ significantly from the whole genome analyses (Table 2 ). The topologies based on conserved domains and diagnostically relevant regions also differed significantly from each other (not shown). Given the conservative nature of the SH test, large amounts of sequence information are needed to obtain tree topologies similar to the complete genome tree (Table 2 ). This agrees with the number of shared partitions between the wholegenome tree and domain-specific trees, which increased as a function of domain length but was never very large for both subtypes 1A and 1B when considering the total number of taxon partitions (maximally 558 and 221, respectively; Fig.  2 ). These findings are corroborated qualitatively by the treeto-tree topological differences of ML trees of PFAM domains, in which, relative to the whole genome tree, the topological distances were shortest for the largest domains (Fig. 3) . Also, when using only synonymous sites for each of the genome partitions, significant evidence was obtained for conflicting tree topologies for all comparisons ( Table 2) . The above findings did not change when using only 30 randomly selected subtype 1A or 1B sequences (not shown), which indicates that the tests employed were not affected by the number or divergence of the sequences used.
DISCUSSION
Given the lack of strongly supported signatures of recombination using many of the standard phylogenetic methods to detect recombination (Table 1) , the large number of gene-conversion tracts between subtypes of HCV as detected by the population-genetic method of Betrán et al. (1997) is striking. As noted above, different phylogenetic optimality criteria do not deal similarly with recombination and, as a consequence, the impact of recombination may vary when using these methods to detect recombination.
Because the results of the phylogenetic and population methods are strikingly different, it may help to examinein an ad hoc manner -the underlying causes of these differences. Methods based on similarity, such as Simplot and the NCBI genotyping tool, rely on a stringent selection of parental and recombinant sequences. Such a selection is difficult, if not impossible, when using large HCV datasets [but see Moreno et al. (2006) for intrapatient analyses] and, as a consequence, these methods cannot be used to infer recombination breakpoints in large datasets. Phylogenetic approaches to detection of recombination are especially compromised (and produce false-negative inferences) if recombination breakpoints occur in many sequences. This is because these breakpoints may lead to a collapse of support in phylogenetic trees, which, in turn leads to difficulties in distinguishing recombinants and parental lineages (see Table 1 ). In this sense, the results of the phylogenetic methods for detection of recombination are as expected. However, maximum-likelihood (ML) methods that rely on tree topologies inferred from portions of a gene or genome such as LARD may still have considerable power to detect differences in tree topologies (see the results of the analyses using RaxML). The ability of these programs to detect recombination depends largely on the amount of data (number of nucleotides and sequences) and its partitioning. As a consequence, the location of recombination breakpoints may be important for inferring recombination using these Columns represent genome start and end positions, numbers of variable sites, fixed or diagnostic differences and shared mutations, numbers of conversion tracts in subtype A (top part) or subtypes A and B (bottom part) and subtype B (top part) or minor subtypes (bottom part), the probability that sites are informative on gene version (y) and the numbers of recombination events estimated using six phylogenetic tests of recombination implemented in the RDP package.
Target
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Journal of General Virology 92 methods. Although ML methods of analysis of partitioned data may detect recombination breakpoints and significant evidence for topological differences in phylogenetic trees, this type of analysis requires a single, preferably wellsupported and unambiguous breakpoint to separate 'unrecombined' genome regions. To test identification of breakpoints in the presence of many recombination signatures, the program GARD was used. It is used to identify whether recombination can be identified in an alignment and to identify the location of breakpoints. Due to memory constraints, the large datasets are not amenable to such analyses. For the three diagnostic genome regions Table 2 . Summary of diversity of conserved PFAM domains and diagnostic targets and ML trees of HCV subtypes 1A and 1B Columns show genome start and end positions, numbers of variable sites with likelihood differences between the ML tree of the entire genome dataset and the partition (DLH), the significance of this difference based on the SH test (Sig.) and the significance of the ML tree of the data partitions according to the ELW test with the posterior probability [ELW (PP)] followed by numbers of synonymous sites with the same information for those sites only. Asterisks mark significant comparisons. Data from HCV whole genomes are used only as a standard for smaller genome regions; NA, not applicable.
Genome position
All with 30 randomly selected sequences, GARD did not find evidence for recombination under a model without rate heterogeneity (which should provide more power than including rate heterogeneity) and using the HKY85 nucleotide substitution model. One hundred randomly selected sequences of the diagnostic regions (the limit for the publicly available version of GARD) indicated no recombination sites. Using 50 whole genomes of subtype 1A and 50 of subtype 1B resulted in two recombination breakpoints. In all, the number of breakpoints did not differ substantially from those identified using the phylogenetic methods (Table 1) .
Although both phylogenetic methods and the method of Betrán et al. (1997) detect only a fraction of the total number of gene conversion or recombination events, the latter method implements a practical approach to detect gene-conversion tracts of two bases or longer while comparing two groups of sequences. Only rare nucleotides are used, which renders parallel mutation unlikely (limit for tracts with two informative sites set to P,0.04; Betrán et al., 1997). In contrast to phylogenetic methods, this allows identification of events in single sequences without an a priori delimitation of seeding and recombinant forms in the presence of high rates of recombination. The characteristic feature of the population estimate of gene conversion is that it takes into account the diversity within and between populations, which renders it suited to analysis of large and complex datasets with many signatures of recombination. In the HCV datasets, many tracts cover multiple consecutive mutations informative for gene conversion, which makes the prime competing process, parallel mutation, highly unlikely (Fig. 1) .
Although it may be argued that tracts with only a few informative nucleotides may still be due to parallel mutation, the larger the number of nucleotides informative for gene conversion, the less likely parallel mutation becomes (Fig. 1) . This is strengthened by the presence of multiple nucleotides in many tracts that have y values close to 1 (not shown), indicating that many of the individual sites are highly informative. The longer tracts are unlikely to be false positives of the population method and, as a consequence, there is support for a substantial number of gene conversion events in HCV subtype 1 (Fig. 1) . Even if only a fraction of the hundreds of gene conversion events between subtypes 1A and 1B were real (Table 1; see  Results) , these can readily be envisaged to hamper the detection of recombination using phylogenetic methods (Table 1 ). In spite of the abundance of recombination tracts, the distribution of indels is unaffected and consistently distinguishes subtype 1A from 1B. 
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The degree of topological conflict between ML trees as measured by the SH test, which requires large amounts of data to detect conflict or incongruence (Strimmer & Rambaut, 2002) , is noteworthy, and further supports a role of recombination throughout the genome of HCV subtype 1. Because the use of synonymous sites gave essentially the same results as analysis of all site types, we conclude that, even if we cannot rule out a role for other processes such as selection and did not target alternative processes such as demographic changes explicitly, recombination has been a major process during HCV subtype 1 evolution.
Genome regions targeted by diagnostic assays also harbour evidence of recombination, as judged from the populationgenetic method. Our analyses also suggest that large amounts of data are required to increase confidence in phylogenetic tree topologies of HCV subtype 1 (Figs 2 and 3 ; Table 1 ), which indicates that further subclassification of HCV subtype 1 should be exercised with caution. The goal of most genotyping tools, however, is not to examine topological congruence of phylogenetic trees, but to distinguish a few (sub)types based on diagnostic sites. It is clear that each diagnostic dataset of HCV subtype 1 includes only a few fixed or diagnostic sites (Table 1 ). In spite of the lack of diagnostically useful base substitutions, subtypes 1A and 1B can be distinguished in phylogenetic trees using only base substitutions (e.g. bootstrap support 99 % for regions 6622-6806 and 7957-8253; not shown), which indicates that assay design may be frustrated by patterns of mutation, even if phylogenetic analysis suggests that the groups to be detected are well separated. In contrast to base substitutions, indels consistently delimit subtypes 1A and 1B. They do not, however, allow fine levels of resolution.
Although many methods have been developed for HCV genotyping, such as sequencing the 59 non-coding region (NCR) or the NS5B gene region (Nakatani et al., 2010) , reverse hybridization using oligonucleotide probes (e.g. INNO-LIPA; e.g. Bouchardeau et al., 2007) and real-time technologies using subtype-specific primers and probes, it is well recognized that a considerable fraction of samples may be misclassified using these methods, which is probably a result of natural sequence variation (e.g. Chevaliez et al., 2009) . Our study indicates that it is not variation per se, but the similar types of nucleotide variation within subtypes associated with recombination, that complicates assay design in HCV subtype 1. More generally, our study indicates that levels of recombination are probably significantly higher than can currently be measured with the tools available.
METHODS
Complete and partial genome sequences of confirmed HCV subtypes 1A, 1B and 1C (Simmonds et al., 2005) and the provisional subtypes 1d-1m (e.g. Viazov et al., 1997; Djebbi et al., 2004; Bracho et al., 2008) were downloaded from the NCBI database, followed by alignment using CLUSTAL_X (Thompson et al., 1997) and identification of open reading frames using DnaSP (Librado & Rozas, 2009 ). For subtyping of HCV, REGA was used under standard option settings. This algorithm uses a fixed set of reference sequences and a cut-off on phylogenetic internode support to infer whether a sequence can be genotyped and classified (Alcantara et al., 2009) . To identify the presence of signatures of recombination, we identified breakpoints using the methods implemented in RDP version 3 under a nominal significance level of 5 % (Martin et al., 2005; Heath et al., 2006) . To assess gene conversion, the population estimator of Betrán et al. (1997) was used. Because this population estimator of gene conversion allows detection of short gene-conversion tracts, is designed to distinguish between recombination and parallel mutation and takes into account the diversity within and between populations, it is a fundamentally different approach compared with phylogenetic approaches (Awadalla, 2003) . A measure of linkage disequilibrium (r 2 ), a measure of the association of nucleotides at different positions, was plotted against physical distance using DnaSP. Under recombination, r 2 is expected to be inversely related to physical distance. The analyses of gene conversion were conducted for both HCV subtypes 1A and 1B as well as the minor subtypes 1c-1g. To assess internode support, bootstrapping was carried out using phylogenetic trees constructed using the composite likelihood distance estimator and neighbour-joining as a clustering criterion as implemented in MEGA 4.1 (Tamura et al., 2007) .
Recombination may leave its traces in the topology of phylogenetic trees in that mutations that are part of a recombination event cannot be plotted uniquely onto a phylogenetic tree. If recombination tracts are restricted to different portions of a genome, these may give rise to topologically distinct phylogenies. To examine whether this holds for HCV subtype 1, we reconstructed ML trees and employed formal tests of topological congruence. To this end, conserved PFAM protein domains and genome regions targeted by molecular diagnostic assays were used as input for a fast ML-based program (RaxML version 7.2.6; Stamatakis, 2006; Stamatakis et al., 2008) . The best ML trees of PFAM domains, the diagnostic targets and the whole genome trees were identified after 100 bootstraps. Using this program, the SH test (Shimodaira & Hasegawa, 1999) and the expected likelihood weights (ELW) test (Strimmer & Rambaut, 2002) were used to assess the congruence of tree topologies based on PFAM domains. In the ELW procedure, confidence sets of trees are delimited, which consist of the smallest subset of the candidate models that together have probability a50.05 as outcomes for a random dataset of length n drawn from the true distribution of tree topologies. In the conservative SH test, the score difference between the ML tree and an alternative tree(s) is compared using non-parametric bootstraps. These tests do not assume that the substitution model or the branching pattern of any of the investigated trees is correct. ML trees were used to determine tree-to-tree distances using PAUP version 4.0 (Swofford, 2003) using symmetrical distances (Penny & Hendy, 1985) . To assess the impact of domain length on topological congruence, the number of shared taxon partitions between ML trees based on PFAM domains and diagnostic targets on the one hand, and whole genome data on the other, was determined. For rooting trees prior to tree-to-tree distance analyses, the outgroup for subtype 1A was isolate HCV-1a/US/BID-V397/2006 (GenBank accession no. EU256050; GI:190684349) and the outgroup for subtype 1B was strain MD25 (GenBank accession no. AF207766; GI:7650249).
